Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - SANDELL SCOTT D
Last Updated 
16-Jan-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

SANDELL SCOTT D: Declared Holdings
Company/RelationshipReportedShares  Ownership
ARCA biopharma, Inc.
Beneficial Owner (10% or more)
NasdaqCM:ABIO
(historical quotes, profile, other insiders)
16-Jun-1510,221,465  Indirect
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
13-Jan-1611,793,223  Indirect
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
Cerecor Inc.
Beneficial Owner (10% or more)
NasdaqCM:CERCU
(historical quotes, other insiders)
20-Oct-15594,245  Indirect
CHAMPIONS ONCOLOGY
Beneficial Owner (10% or more)
NasdaqCM:CSBR
(historical quotes, profile, other insiders)
11-Mar-1518,750,000  Indirect
Tableau Software, Inc. Class A
Director
NYSE:DATA
(historical quotes, profile, other insiders)
5-Dec-1455,705  Indirect
GlycoMimetics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
16-Nov-158,584,128  Indirect
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
Roka Bioscience, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,216,810  Indirect
Sunesis Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqCM:SNSS
(historical quotes, profile, other insiders)
29-Aug-144,659,333  Indirect
Supernus Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
11-Nov-154,116,086  Indirect
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:VTAE
(historical quotes, profile, other insiders)
1-Jul-151,788,254  Indirect
Workday, Inc. Common Stock
Director
NYSE:WDAY
(historical quotes, profile, other insiders)
28-Feb-145,088  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
13-Jan-16 *1,500,000ARDX Purchase at $10 per share.
(Cost of $15,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
16-Nov-15 *9,445GLYC Option Exercise at $0.33 per share.
(Cost of $3,116)
16-Nov-15 *452GLYC Sale at $6.91 per share.
(Proceeds of $3,123)
11-Nov-15 *4,993,557SUPN Disposition (Non Open Market) at $0 per share.
11-Nov-15 *1,468,393SUPN Acquisition (Non Open Market) at $0 per share.
20-Oct-15 *594,245CERCU Acquisition (Non Open Market)
6-Oct-15 *857,142MIRN Purchase at $7 per share.
(Cost of $5,999,994)
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
1-Jul-15 *9,940VTAE Acquisition (Non Open Market) at $0 per share.
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
17-Jun-15 *136,597SUPN Sale at $16.02 - $17.03 per share.
(Proceeds of about $2,257,000)
16-Jun-15 *10,221,465ABIO Statement of Ownership
16-Jun-15 *95,437SUPN Sale at $16.85 - $17.01 per share.
(Proceeds of about $1,616,000)
15-Jun-15 *1,153,034SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
5-Jun-15 *4,672,897ARDX Purchase at $10.70 per share.
(Cost of $49,999,997)
11-Mar-15 *18,750,000CSBR Statement of Ownership
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
26-Dec-14 *1,972ARDX Sale at $21.28 per share.
(Proceeds of $41,964)
23-Dec-14 *2,564ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
23-Dec-14 *19,868,965ILIU Purchase at $0.10 per share.
(Cost of $1,986,896)
5-Dec-14 *17,123DATA Sale at $81.76 per share.
(Proceeds of $1,399,976)
4-Dec-14 *34,786DATA Sale at $80.78 - $81.32 per share.
(Proceeds of about $2,819,000)
3-Dec-14 *17,663DATA Sale at $81.48 per share.
(Proceeds of $1,439,181)
2-Dec-14 *1,730,428DATA Acquisition (Non Open Market) at $0 per share.
2-Dec-14 *1,633,750DATA Disposition (Non Open Market) at $0 per share.
10-Nov-14 *6,250DATA Disposition (Non Open Market) at $0 per share.
29-Aug-14 *11,600SNSS Sale at $7.51 per share.
(Proceeds of $87,116)
28-Aug-14 *146,800SNSS Sale at $7.87 per share.
(Proceeds of $1,155,316)
27-Aug-14 *108,300SNSS Sale at $8.17 per share.
(Proceeds of $884,811)
25-Aug-14 *7,099DATA Sale at $60.40 per share.
(Proceeds of $428,779)
22-Aug-14 *52,312DATA Sale at $60.46 - $61.02 per share.
(Proceeds of about $3,177,000)
21-Aug-14 *30,000DATA Sale at $59.19 - $59.79 per share.
(Proceeds of about $1,785,000)
20-Aug-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
20-Aug-14 *2,224,734DATA Acquisition (Non Open Market) at $0 per share.
12-Aug-14 *35,540SNSS Sale at $6.76 per share.
(Proceeds of $240,250)
8-Aug-14 *675,000SNSS Sale at $6.62 per share.
(Proceeds of $4,468,500)
6-Aug-14 *230,769LOXO Purchase at $13 per share.
(Cost of $2,999,997)
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
22-Jul-14 *2,828,743ROKA Acquisition (Non Open Market)
22-Jul-14 *383,333ROKA Purchase at $12 per share.
(Cost of $4,599,996)
16-Jul-14 *4,734ROKA Statement of Ownership
7-Mar-14 *23,624DATA Sale at $90.62 - $93.07 per share.
(Proceeds of about $2,170,000)
6-Mar-14 *84,849DATA Sale at $94.32 - $96.13 per share.
(Proceeds of about $8,080,000)
5-Mar-14 *35,000DATA Sale at $94.28 - $95.34 per share.
(Proceeds of about $3,318,000)
4-Mar-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
4-Mar-14 *10,804DATA Sale at $97.31 per share.
(Proceeds of $1,051,337)
4-Mar-14 *2,224,751DATA Acquisition (Non Open Market) at $0 per share.
3-Mar-14 *30,000DATA Sale at $95.14 - $96 per share.
(Proceeds of about $2,867,000)
28-Feb-14 *4,930WDAY Sale at $105.18 - $110.74 per share.
(Proceeds of about $532,000)
27-Feb-14 *188,452DATA Sale at $94.47 - $97.11 per share.
(Proceeds of about $18,052,000)
26-Feb-14 *4,449,401DATA Acquisition (Non Open Market) at $0 per share.
26-Feb-14 *4,200,949DATA Disposition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?